The Rice Alliance for Technology and Entrepreneurship together with BioHouston will organize the 14th Annual Texas Life Science Forum in Houston on November 11, 2025. This notable event acts as a pillar of life science innovation in Texas by bringing together leaders from various sectors like industry, academia, clinical research, and investment communities. The forum showcases the latest advancements in therapeutics, medical technology, and digital health.
Health Technology Insights: Mosaiq Aiplex Vasculitis Assay Now CE Mark Approved
With both organizations having a shared goal of promoting healthcare innovation and the life sciences industry, the event supports the entire commercialization process, starting from early discovery and academic research, progressing through startup development, clinical trials, and market launch. Attendees benefit from educational presentations, networking opportunities, and collaborations between entrepreneurs, investors, researchers, and corporate executives, all focused on turning scientific discoveries into practical healthcare solutions.
Jeffrey L. Wade, Chairman of BioHouston, stated, “Houston is a hub of life-science innovation. The Texas Life Science Forum showcases emerging therapeutics, medical solutions, and digital health platforms with the potential to revolutionize patient care. We’re proud to host exciting startups and innovative growth companies on a platform where science meets capital.”
Health Technology Insights: Afaxys Secures $8 Million to Advance Mission and Accelerate Growth Strategy
BioHouston and Rice Alliance have started accepting applications from life science ventures wishing to participate in this year’s forum. According to Brad Burke, Associate Vice President for Industry and New Ventures at Rice University’s Office of Innovation and Executive Director of Rice Alliance for Technology and Entrepreneurship, “We’re searching for the best early to growth stage companies from across the country to participate in the Texas Life Science Forum. This is a chance for pioneering life science companies to interface with Houston’s life science investors and industry leaders, including the Texas Medical Center, the world’s largest medical center.”
The deadline for venture applications is Friday, September 26, 2025. Selected companies have the opportunity to present their innovations in therapeutics, medical devices, and digital health directly to potential investors. The program will encompass venture pitches featuring presentations of investment-ready ideas, keynote panels discussing market trends, regulatory challenges, and commercialization strategies, and networking sessions to encourage collaborations between researchers, entrepreneurs, and investors.
Houston’s life science sector continues to develop as a globally competitive hotspot for healthcare innovation, hosting top medical schools and major biomedical research institutions like the world’s leading cancer center and largest children’s hospital. This dynamic ecosystem fuels transformative medical discoveries and is fast emerging as one of the country’s most dynamic life science markets. The Texas Life Science Forum fuels this environment by convening diverse stakeholders to help advance groundbreaking science into practical healthcare solutions.
Health Technology Insights: TransMedics Receives FDA IDE Approval to Initiate Next-Generation OCS Heart Trial
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
